Ukrike Lorch, MD FRCA FFPM

Co-founder & Medical Director
Richmond Pharmacology Ltd
London, England, United Kingdom

Presentation(s):

• Poster Number-64 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: III. Phase-1 Study

  Poster Abstracts